-
EP2496260
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2496260
| EP2496260 - ACTIVITY GENERATING DELIVERY MOLECULES [Right-click to bookmark this link] | Status | The application has been refused Status updated on 10.04.2020 Database last updated on 09.09.2024 | |
| Former | Examination is in progress Status updated on 05.12.2016 | Most recent event Tooltip | 10.04.2020 | Refusal of application | published on 13.05.2020 [2020/20] | Applicant(s) | For all designated states Marina Biotech, Inc. 3830 Monte Villa Parkway Bothell, WA 98021 / US | [2012/37] | Inventor(s) | 01 /
FAM, Renata 6233 NE 193rd Ct Kenmore, WA 98028 / US | 02 /
ADAMI, Roger C. 18719 36th Dr SE Bothell, WA 98012 / US | 03 /
FOSNAUGH, Kathy L. 1907 162nd Ave NE Bellevue, WA 98008 / US | 04 /
HARVIE, Pierrot 19310 Bothell Way NE 213 Bothell, WA 98011 / US | 05 /
JOHNS, Rachel E. 2503 NE 150th St Shoreline, WA 98155 / US | 06 /
SETH, Shaguna 20032 34th Ave SE Bothell, WA 98012 / US | 07 /
HOUSTON JR., Michael E. 22103 NE 26th Place Sammamish, WA 98074 / US | 08 /
TEMPLIN, Michael V. 19112 30th Dr SE Bothell, WA 98012 / US | [2012/37] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2012/37] | Srinivasan, Ravi Chandran J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 10782465.8 | 04.11.2010 | WO2010US55516 | Priority number, date | US20090258115P | 04.11.2009 Original published format: US 258115 P | [2012/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011057020 | Date: | 12.05.2011 | Language: | EN | [2011/19] | Type: | A1 Application with search report | No.: | EP2496260 | Date: | 12.09.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.05.2011 takes the place of the publication of the European patent application. | [2012/37] | Search report(s) | International search report - published on: | EP | 12.05.2011 | Classification | IPC: | A61K47/00, A61K48/00 | [2012/37] | CPC: |
A61K31/16 (EP,US);
A61K31/401 (EP,US);
A61K31/4172 (EP,US);
A61K31/713 (EP,US);
A61K47/00 (EP,US);
A61K47/18 (US);
A61K47/22 (US);
A61K48/00 (EP,US);
A61K9/0019 (EP,US);
A61K9/127 (EP,US);
A61P1/16 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/06 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P9/00 (EP);
C07C237/52 (US);
C07D207/16 (EP,US);
C07D233/64 (EP,US);
C12N15/1137 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/37] | Title | German: | AKTIVITÄTSERZEUGENDE FREISETZUNGSMOLEKÜLE | [2012/37] | English: | ACTIVITY GENERATING DELIVERY MOLECULES | [2012/37] | French: | MOLÉCULES D'ADMINISTRATION GÉNÉRATRICES D'ACTIVITÉ | [2012/37] | Entry into regional phase | 01.06.2012 | National basic fee paid | 01.06.2012 | Designation fee(s) paid | 01.06.2012 | Examination fee paid | Examination procedure | 01.06.2012 | Examination requested [2012/37] | 21.12.2012 | Amendment by applicant (claims and/or description) | 10.07.2014 | Despatch of a communication from the examining division (Time limit: M06) | 20.01.2015 | Reply to a communication from the examining division | 12.02.2016 | Despatch of a communication from the examining division (Time limit: M06) | 23.09.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 02.12.2016 | Reply to a communication from the examining division | 18.09.2018 | Date of oral proceedings | 01.10.2018 | Despatch of communication that the application is refused, reason: substantive examination [2020/20] | 01.10.2018 | Minutes of oral proceedings despatched | 24.03.2020 | Application refused, date of legal effect [2020/20] | Appeal following examination | 27.11.2018 | Appeal received No. T0472/19 | 08.01.2019 | Statement of grounds filed | 24.03.2020 | Result of appeal procedure: appeal of the applicant withdrawn | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.07.2014 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 02.12.2016 | Request for further processing filed | 02.12.2016 | Full payment received (date of receipt of payment) Request granted | 16.12.2016 | Decision despatched | Fees paid | Renewal fee | 13.11.2012 | Renewal fee patent year 03 | 01.05.2014 | Renewal fee patent year 04 | 10.11.2014 | Renewal fee patent year 05 | 10.11.2015 | Renewal fee patent year 06 | 23.05.2017 | Renewal fee patent year 07 | 20.04.2018 | Renewal fee patent year 08 | 28.11.2018 | Renewal fee patent year 09 | 27.11.2019 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 30.11.2013 | 04 M06 Fee paid on 01.05.2014 | 30.11.2016 | 07 M06 Fee paid on 23.05.2017 | 30.11.2017 | 08 M06 Fee paid on 20.04.2018 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2008137758 (NASTECH PHARM CO [US], et al) [Y] 1-29 * page 92 - page 138; claims 1-49 *; | [Y]WO2009046220 (MDRNA INC [US], et al) [Y] 1-29 * claim 1 *; | [Y] - GASCON A R ET AL, "Cationic lipids as gene transfer agents: a patent review", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, (20080101), vol. 18, no. 5, doi:DOI:10.1517/13543770802102877, ISSN 1354-3776, pages 515 - 524, XP002510683 [Y] 1-29 * page 516 - page 518 * DOI: http://dx.doi.org/10.1517/13543770802102877 | by applicant | WO2008147824 | US2008317839 | US2010112042 | - DONALD VOET; JUDITH VOET, Biochemistry, (2005), page 383 | - BERGE ET AL., J. PHARM. SCI., (1977), vol. 66, pages 1 - 19 |